Scientists test Gene-Altered cells to fight HIV in cancer patients
NCT ID NCT03593187
Summary
This study tested the safety of a new gene therapy for people living with HIV who also have a high-risk type of lymphoma (a blood cancer). Researchers collected a patient's own blood cells, modified them with a gene designed to resist HIV, and then gave them back after a stem cell transplant. The main goals were to see if this procedure was safe and if the modified cells successfully took hold in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Saint Louis
Paris, 75475, France
Conditions
Explore the condition pages connected to this study.